admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Psyched Wellness Provides Update on Anti-Inflammatory Study with the National Research...

PharmaDrug Announces Initiation of Manufacturing of Cepharanthine (PD-001) For Clinical Programs...

MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2022

Awakn Life Sciences Files Patent Application for a New Class of...

PT287 – Josh Hardman – Psychedelic Stocks, Data Privacy, and Drug...

Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical...

FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety...

Mydecine Partners with Combat Stress to Treat Post-Traumatic Stress Disorder in...

Algernon Pharmaceuticals Discloses Novel Salt Patent Strategy as Part of its...

Beckley Psytech Announces First Cohort of Psychotherapists Have Begun Training for...

1...162163164...218 Page 163 of 218

The Interdisciplinary Annotated Psychedelic Research Bibliography of 2024

Reflections on the 2025 Federal Policy Summit on Psychedelic Medicine

Spring 2025 Psychedelic Policy Update: Bills Hang in the Balance as...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin